Verastem Oncology (VSTM) Misses Q1 EPS by 43c

Verastem Oncology (NASDAQ: VSTM) reported Q1 EPS of ($0.43). Revenue for the quarter came in at $18.67 million.

For earnings history and earnings-related data on Verastem Oncology (VSTM) click here.

You May Also Be Interested In

• INVO Fertility (IVF) Tops Q2 EPS by 105c
• BitFuFu Inc. (FUFU) Misses Q2 EPS by 13c
• Bitmine reports 5.82 million ETH holdings, $11.4B total assets